Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN000617 | 78.96 | 0.84 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 79.96 | 3.28 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 85.03 | 0.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 87.05 | 1.04 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 89.03 | 0.82 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 92.93 | 0.61 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 93.04 | 1.59 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 94.93 | 0.61 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 96.92 | 0.61 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 99.05 | 1.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 101.03 | 0.69 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 103.04 | 0.92 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 107.05 | 2.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 107.05 | 3.3 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 108.9 | 0.62 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 110.9 | 0.62 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 111.01 | 0.69 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 112.05 | 0.6 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 115 | 0.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 115 | 1.08 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 115.04 | 1.1 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 117.02 | 0.81 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 117.06 | 1.24 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 121.03 | 1.59 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 121.03 | 2.21 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 124.01 | 0.62 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 124.99 | 0.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 128.04 | 0.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 129.02 | 0.68 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 129.06 | 1.62 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 130.06 | 0.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 131.04 | 1.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 131.07 | 1.61 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 132.03 | 0.69 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 132.95 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 133.02 | 0.68 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 133.05 | 0.78 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 134.06 | 2.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 134.9 | 0.73 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 135.03 | 0.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 137.03 | 0.96 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 137.03 | 1.71 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 141.09 | 5.29 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 143.04 | 1.52 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 143.07 | 1.78 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 144.05 | 4.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 144.05 | 5.31 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 144.07 | 0.92 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 145.05 | 1.45 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 145.06 | 2.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 146.05 | 0.68 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 147.03 | 0.69 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 147.07 | 1.14 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 148.03 | 0.63 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 149.05 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 150.89 | 0.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 151.01 | 0.69 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 151.04 | 2.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 151.04 | 3.24 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 151.04 | 3.87 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 151.06 | 0.6 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 152.88 | 0.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 154.06 | 0.61 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 154.93 | 0.72 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 155.05 | 0.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 155.11 | 5.93 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 156.07 | 1.81 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 156.99 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 157.03 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 157.05 | 1.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 157.12 | 6.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 158.08 | 1.15 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 158.08 | 2.03 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 158.99 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 159.03 | 0.68 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 159.07 | 2.82 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 159.1 | 4.93 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 160.06 | 0.73 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 160.84 | 0.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 161.05 | 0.91 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 162.84 | 0.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 163.06 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 164.04 | 3.54 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 165.04 | 0.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 165.06 | 3.81 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 167.02 | 0.71 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 167.04 | 1.09 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 167.11 | 7.17 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 168.03 | 1.13 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 170.08 | 3.77 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 171.04 | 0.74 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 171.07 | 3.24 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 172.1 | 3.6 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 172.1 | 4.11 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 172.99 | 1.59 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 173.01 | 0.68 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 173.08 | 4 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 173.99 | 0.73 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 174.03 | 0.68 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 174.99 | 1.59 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 175.02 | 0.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 175.03 | 3.47 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 176.98 | 0.54 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 177.02 | 0.96 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 177.04 | 0.73 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 179.05 | 1.72 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 179.05 | 2.42 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 179.06 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 180.07 | 3.09 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 181.04 | 0.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 181.05 | 1.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 181.06 | 3.12 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 181.07 | 0.6 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 181.99 | 1.23 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 182.05 | 0.82 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 182.08 | 3.74 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 183.02 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 184.1 | 3.98 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 185.08 | 4.49 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 187.04 | 0.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 187.1 | 4.94 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 187.13 | 3.28 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 188 | 0.74 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 188.01 | 3.3 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 188.04 | 1.5 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 188.06 | 0.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 188.99 | 1.34 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 189 | 0.71 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 189.01 | 3.31 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 189.04 | 0.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 189.11 | 4.93 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 190.05 | 3.3 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 190.99 | 1.34 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 191.02 | 0.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 192.03 | 1.74 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 192.07 | 4.05 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 192.98 | 0.77 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 193.03 | 0.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 193.04 | 3.47 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 193.04 | 3.74 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 193.04 | 4.2 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 193.04 | 4.91 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 193.04 | 5.29 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 193.04 | 5.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 193.04 | 7.35 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 193.06 | 1.72 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 193.82 | 0.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 194.05 | 1.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 194.05 | 3.37 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 195.05 | 0.99 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 195.05 | 1.28 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 195.07 | 3.98 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 195.81 | 1.9 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 195.81 | 2.47 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 195.81 | 3.3 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 197.05 | 0.84 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 197.06 | 0.73 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 197.08 | 4.51 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 197.81 | 2.47 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 197.81 | 3.29 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 197.81 | 4.34 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 198.11 | 5.52 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 198.11 | 6.28 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 199.01 | 4.17 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 199.04 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 199.1 | 5.38 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 199.81 | 0.77 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 199.81 | 1.78 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 199.81 | 2.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 199.81 | 3.28 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 200.13 | 6.24 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 201.02 | 4.71 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 201.03 | 0.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 201.05 | 0.65 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 201.11 | 4 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 201.11 | 5.76 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 201.8 | 0.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 202.05 | 3.63 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 202.06 | 3.09 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 202.11 | 4.02 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 202.97 | 6.69 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 203 | 1.98 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 203 | 2.84 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 203 | 3.08 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 203.03 | 0.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 203.08 | 1.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 204.02 | 1.87 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 204.07 | 4.49 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 204.98 | 1.15 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 205.04 | 0.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 205.09 | 5.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 206.08 | 4.03 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 206.99 | 1.11 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 208.06 | 3.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 209.08 | 4.94 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 211.05 | 1.38 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 211.08 | 1.15 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 211.1 | 7.17 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 212 | 1.82 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 213.02 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 213.11 | 5.94 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 214 | 1.79 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 214.03 | 2.42 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 215.03 | 0.63 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 215.09 | 3.78 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 215.09 | 4.29 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 215.1 | 0.84 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 215.13 | 6.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 216.03 | 2.42 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 216.04 | 0.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 216.09 | 0.9 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 216.93 | 0.79 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 217.05 | 0.63 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 217.11 | 3.62 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 217.11 | 4.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 218.05 | 0.87 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 218.1 | 1.22 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 219 | 1.01 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 219 | 1.79 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 219.05 | 0.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 219.05 | 0.87 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 219.06 | 4.72 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 220.05 | 0.68 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 220.06 | 0.99 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 222.99 | 0.83 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 223.02 | 5.37 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 223.08 | 4.94 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 224.06 | 1.49 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 225.07 | 0.91 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 225.08 | 5.1 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 225.09 | 1.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 225.11 | 3.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 225.11 | 6.35 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 227.04 | 0.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 227.13 | 6.78 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 229.02 | 4.81 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 229.05 | 6.15 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 229.15 | 7.21 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 230.02 | 1.1 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 230.02 | 1.37 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 231 | 1.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 231 | 1.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 231 | 3.38 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 231.12 | 4.84 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 232.02 | 1.11 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 232.98 | 0.99 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 233.01 | 1.05 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 233.04 | 0.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 234.11 | 5.82 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 236.01 | 2.47 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 236.09 | 4.23 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 237.09 | 4 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 238.01 | 2.45 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 238.08 | 5.34 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 239 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 239.09 | 4.03 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 239.09 | 5.73 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 239.09 | 7.17 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 241.07 | 5.14 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 241.09 | 0.6 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 241.11 | 4.93 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 241.12 | 3.21 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 243.03 | 5.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 243.06 | 0.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 243.12 | 4.62 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 243.12 | 5.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 243.14 | 3.74 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 244.07 | 0.62 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 244.97 | 3.29 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 245.01 | 2.29 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 245.01 | 4.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 245.05 | 0.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 245.05 | 4.9 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 245.11 | 0.99 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 245.14 | 4.93 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 245.14 | 5.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 246.08 | 4.6 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 246.15 | 6.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 246.99 | 1.05 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 247.06 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 248.06 | 1.69 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 248.1 | 4.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 249 | 0.78 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 252 | 1.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 253.11 | 6.47 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 253.15 | 8.01 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 254.08 | 1.21 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 254.62 | 7.33 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 254.98 | 0.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 255.09 | 7.17 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 255.14 | 4.13 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 255.63 | 7.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 256.06 | 0.63 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 256.94 | 0.59 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 257.15 | 4.65 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 258.05 | 0.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 258.07 | 0.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 259.12 | 3.94 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 260.05 | 2.48 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 260.06 | 0.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 261.01 | 1.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 261.09 | 3.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 261.13 | 3.93 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 262.62 | 6.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 263.06 | 0.65 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 263.1 | 2.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 263.11 | 5.93 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 263.63 | 7.35 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 264.09 | 3.52 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 264.09 | 3.94 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 265.11 | 2.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 265.12 | 4.49 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 267.12 | 5.91 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 267.13 | 8.17 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 267.14 | 4.4 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 269.01 | 3.31 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 269.07 | 1.8 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 269.15 | 5.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 271.16 | 6.84 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 273.01 | 2.09 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 273.01 | 2.16 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 273.17 | 5.51 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 273.17 | 6.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 274 | 0.96 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 275.02 | 2.23 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 275.07 | 4.37 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 276.03 | 2.38 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 276.09 | 4.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 277.07 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 279.05 | 0.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 279.1 | 1.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 279.1 | 3.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 279.14 | 5.22 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 279.91 | 0.8 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 280.98 | 0.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 281.11 | 4.02 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 282.05 | 1.38 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 282.98 | 0.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 283.03 | 0.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 283.08 | 3.54 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 283.12 | 5.63 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 283.12 | 8.17 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 283.17 | 6.13 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 285.03 | 0.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 285.05 | 4.95 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 285.07 | 4.95 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 287.02 | 2.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 292.02 | 1.27 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 293.04 | 0.99 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 295.08 | 4.13 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 295.13 | 3.51 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 297.1 | 4.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 298.01 | 2.41 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 298.04 | 0.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 298.06 | 0.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 299.08 | 2.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 299.64 | 5.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 301.08 | 2.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 303.07 | 1.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 304.12 | 6.21 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 305.02 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 305.13 | 5.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 305.16 | 6.62 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 305.91 | 1.59 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 307.12 | 5.02 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 309.18 | 9.69 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 311.88 | 2.18 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 313.09 | 4.05 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 313.88 | 2.18 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 314 | 1.22 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 314.9 | 0.62 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 315.89 | 0.78 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 316.09 | 3.22 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 316.89 | 0.59 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 317.11 | 0.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 317.12 | 5.45 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 318.99 | 0.53 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 319.06 | 8.21 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 319.14 | 6.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 319.19 | 5.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 321 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 321.06 | 2.84 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 322.06 | 2.81 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 323.06 | 2.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 323.08 | 0.63 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 323.18 | 7.56 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 324.07 | 1.28 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 325.09 | 4.44 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 325.13 | 6.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 327.11 | 5.05 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 329.07 | 5.04 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 329.11 | 5.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 329.16 | 6.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 331.14 | 6.3 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 331.18 | 7.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 333.01 | 4.31 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 335.14 | 4.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 336.05 | 2.48 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 336.07 | 3.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 336.97 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 338.89 | 2.42 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 338.94 | 0.59 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 339.11 | 5.2 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 340.89 | 2.42 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 341.04 | 3.54 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 341.09 | 4.09 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 341.12 | 4.09 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 341.12 | 5.87 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 342.89 | 2.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 343.04 | 0.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 343.07 | 1.19 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 343.09 | 5.42 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 343.14 | 6.15 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 343.14 | 6.54 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 345.11 | 2.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 345.16 | 3.91 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 345.16 | 5.04 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 345.16 | 5.2 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 345.16 | 6.94 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 345.16 | 7.2 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 347.17 | 5.13 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 347.22 | 7.56 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 349.06 | 8.89 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 349.15 | 4.11 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 349.2 | 6.97 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 351.15 | 5.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 352.09 | 6.02 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 353.03 | 5.53 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 354.1 | 5.81 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 354.89 | 1.15 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 356.12 | 6.08 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 357.1 | 5.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 357.11 | 2.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 359.13 | 4.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 359.14 | 4.2 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 359.17 | 7.72 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 361.08 | 2.84 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 361.15 | 4.56 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 361.15 | 4.97 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 362.98 | 0.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 363.08 | 4.26 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 363.11 | 4.25 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 363.13 | 4 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 363.16 | 4.02 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 364.07 | 3.45 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 364.98 | 0.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 365.03 | 0.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 365.08 | 3.49 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 366.08 | 3.46 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 366.09 | 6.02 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 366.1 | 3.46 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 367.15 | 7.02 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 367.21 | 6.74 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 369.16 | 6.21 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 369.16 | 7.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 369.17 | 6.24 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 369.17 | 7.35 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 371.11 | 3.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 371.13 | 3.45 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 372.11 | 4.17 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 373.11 | 4.12 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 373.15 | 4.92 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 375.13 | 4.28 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 375.17 | 5.02 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 377.09 | 0.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 377.15 | 3.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 378.96 | 0.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 379.09 | 2.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 379.16 | 4.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 381.13 | 5.18 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 383.06 | 2.8 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 383.15 | 4.92 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 383.15 | 5.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 383.17 | 4.92 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 383.17 | 5.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 385.16 | 4.81 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 385.16 | 5.18 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 385.17 | 5.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 385.17 | 5.79 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 385.18 | 5.18 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 387.03 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 387.17 | 5.13 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 387.17 | 6.05 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 387.18 | 5.13 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 387.19 | 5.78 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 387.2 | 4.83 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 389.09 | 5.13 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 389.1 | 1.3 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 389.13 | 5.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 389.14 | 5.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 389.14 | 7.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 389.18 | 7.38 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 389.21 | 5.82 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 391.13 | 7.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 395.16 | 6.22 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 395.21 | 8.04 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 397 | 3.28 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 397.15 | 4.92 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 397.18 | 4.92 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 397.18 | 5.74 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 398.9 | 2.45 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 399.16 | 3.56 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 400.14 | 5.08 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 401.15 | 5.28 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 401.16 | 4.09 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 401.17 | 5.49 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 401.18 | 3.76 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 401.18 | 4.65 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 401.18 | 6.48 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 402.16 | 5.34 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 403 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 403.11 | 5.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 403.17 | 4.48 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 405.18 | 5.13 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 411.2 | 5.76 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 411.2 | 6.53 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 411.2 | 8.51 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 413.18 | 7.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 413.19 | 6.42 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 413.19 | 7.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 413.21 | 5.63 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 413.22 | 7.61 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 415.2 | 6.94 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 416.14 | 3.95 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 417.21 | 7.38 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 418.98 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 419.23 | 7.81 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 420.94 | 0.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 421.06 | 6.21 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 423.13 | 6 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 423.95 | 2.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 425.15 | 4.77 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 425.15 | 6.39 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 425.18 | 5.4 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 425.18 | 5.9 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 425.94 | 2.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 427.16 | 5.08 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 427.19 | 6.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 427.2 | 5.89 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 429.08 | 3.44 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 429.18 | 5.53 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 429.18 | 6.5 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 429.18 | 7.08 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 429.2 | 5.31 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 429.21 | 7.09 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 431.23 | 6.2 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 433.21 | 5.33 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 433.21 | 6.48 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 434.21 | 6.04 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 435.22 | 7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 437.05 | 2.45 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 437.06 | 6.7 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 439.16 | 4.48 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 439.16 | 5.3 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 439.2 | 7.56 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 441.16 | 5.89 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 441.21 | 7.23 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 442.19 | 6.61 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 443.14 | 5.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 443.16 | 7.27 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 443.17 | 5.53 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 444.99 | 0.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 445.19 | 5.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 445.2 | 5.11 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 445.21 | 5.67 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 446.29 | 7.81 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 447.03 | 0.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 449.04 | 0.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 449.2 | 5.1 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 449.25 | 8.98 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 451.07 | 6.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 455.19 | 6.03 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 459.15 | 7.27 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 460.29 | 7.6 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 461.16 | 5.33 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 461.24 | 7.3 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 462.18 | 5.91 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 463.23 | 7.17 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 464.14 | 2.69 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 464.3 | 6.8 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 465.14 | 7.11 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 465.25 | 7.47 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 469.03 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 469.18 | 7.18 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 469.23 | 7.18 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 471.24 | 7.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 475.15 | 4.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 477.16 | 7.35 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 479.23 | 6.45 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 481.24 | 6.26 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 481.97 | 2.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 485 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 485.17 | 5.02 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 487.13 | 5.17 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 489.17 | 7.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 489.27 | 7.83 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 493.19 | 6.09 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 493.23 | 6.09 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 493.24 | 7.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 493.27 | 7.77 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 495.22 | 4.37 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 495.26 | 7.93 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 495.3 | 7.79 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 497.28 | 7.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 500.98 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 503.19 | 5.65 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 505.27 | 6.78 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 507.04 | 0.54 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 507.21 | 5.79 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 509.24 | 7.26 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 509.27 | 7.26 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 509.28 | 6.04 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 509.28 | 7.64 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 510.25 | 7.33 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 511.25 | 6.18 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 511.27 | 7.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 511.29 | 7.38 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 512.27 | 7.84 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 513.27 | 7.37 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 516.95 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 523.21 | 7.48 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 523.25 | 6.61 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 525.27 | 6.06 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 525.27 | 6.93 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 526.25 | 6.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 526.99 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 527.21 | 2.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 528.26 | 7.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 529.04 | 0.56 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 529.22 | 7.74 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 529.27 | 6.22 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 539.25 | 5.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 541.27 | 5.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 542.27 | 6.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 543.28 | 5.45 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 543.28 | 5.89 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 547.25 | 7.48 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 549.2 | 2.85 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 550.24 | 7.36 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 551.03 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 551.2 | 7.74 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 553.25 | 7.78 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 567.01 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 567.04 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 567.32 | 7.32 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 572.25 | 4.95 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 574.11 | 2.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 575.25 | 7.75 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 580.13 | 2.43 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 582.98 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 594.36 | 7.24 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 597.21 | 5.86 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 598.96 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 599.22 | 5.66 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 600.28 | 5.58 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 602.3 | 5.61 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 607.16 | 2.84 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 608.99 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 611.04 | 0.56 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 613.36 | 7.4 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 621.25 | 6.18 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 624.97 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 627.37 | 7.55 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 633.04 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 649.01 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 663.36 | 7.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 664.98 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 680.96 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 685.34 | 7.07 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 691 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 715.04 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 731.01 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 746.99 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 797.04 | 0.56 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 813.02 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 828.99 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 895.02 | 0.57 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine | |
| AN000617 | 1108.01 | 3.29 | Minutes | ST000382 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Urine |
